Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 176

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations

Open access
Redis, Roxana S, Sieuwerts, Anieta M, Look, Maxime P, Tudoran, Oana, Ivan, Cristina, Spizzo, Riccardo, Zhang, Xinna, de Weerd, Vanja, Shimizu, Masayoshi, Ling, Hui, Buiga, Rares, Pop, Victor, Irimie, Alexandru, Fodde, Riccardo, Bedrosian, Isabella, Martens, John WM, Foekens, John A, Berindan-Neagoe, Ioana, Calin, George A · 2013 · Oncotarget

Abstract

// Roxana S Redis 1,3,* , Anieta M Sieuwerts 2,* , Maxime P Look 2 , Oana Tudoran 4 , Cristina Ivan 6 , Riccardo Spizzo 5 , Xinna Zhang 6 , Vanja de Weerd 2 , Masayoshi Shimizu 1 , Hui Ling 1 , Rares Buiga 10 , Victor Pop 3 , Alexandru Irimie 11 , Riccardo Fodde 7 , Isabella Bedrosian 8 , John WM Martens 2 , John A Foekens 2 , Ioana Berindan-Neagoe 4,9 , George A Calin 1,7 1 Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. 2 Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical, Rotterdam, The Netherlands 3 Department of Molecular Science, University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania. 4 Department of Functional Genomics, The Oncology Institute, Cluj-Napoca, Romania. 5 Division of Experimental Oncology, CRO, National Cancer Institute, Aviano, Italy. 6 Center for RNA Interference and Non-coding RNAs The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. 7 Department of Pathology, Josephine Nefkens Institute, Erasmus Medical Center, Rotterdam, The Netherlands. 8 Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. 9 Research Center for Functional Genomics, Biomedicine and Translational Medicine, University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania. 10 Department of Pathology, The Oncology Institute, Cluj-Napoca, Romania 11 Department of Surgical and Gynecology Oncology, University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania. * These authors contributed equally to this work Correspondence: George A. Calin, email: // Ioana Berindan-Neagoe, email: // Keywords : non coding RNA, CCAT2, breast cancer, prognosis, real-time PCR. Received : August 15, 2013 Accepted : September 16, 2013 Published : September 18, 2013 Abstract The clinical outcome of BC patients receiving the same treatment is known to vary considerably and thus, there is a compelling need to identify novel biomarkers that can select the patients that would benefit most from a given therapy and can predict the clinical outcome. The aim of this study was to determine the prognostic value of CCAT2 , a novel long ncRNA recently characterized by our group and overlapping SNP rs6983267, in BC patients. We first evaluated by RT-qPCR and ISH the expression of CCAT2 in normal breast tissue and BC tissue and further analyzed CCAT2 expression in an independent set of 997 primary BC with regard to clinical, histological, pathological and other biological factors. Also, we explored the possibility of CCAT2 adding to the prognostic value of multivariate models that already included the traditional prognostic factors. Finally, we identified in in vitro models the impact of CCAT2 expression and SNP rs6983267 genotype on cell migration and chemoresistance. Our results revealed that although overexpressed in BCs in two out of three sets of patients, and having the highest expression in lymph node negative (LNN) disease, CCAT2 expression levels are informative solely for a subgroup of BC patients, namely for patients with LNP disease that have received adjuvant CMF chemotherapy. For this subgroup high levels of CCAT2 suggest the patients will not benefit from CMF containing adjuvant chemotherapy (shorter MFS and OS). Additionally, we found that CCAT2 upregulates cell migration and downregulates chemosensitivity to 5’FU in a rs6983267-independent manner.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.1292

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

Metadata

Authors
Redis, R. S., Sieuwerts, A. M., Look, M. P., Tudoran, O., Ivan, C., Spizzo, R., Zhang, X., de Weerd, V., Shimizu, M., Ling, H., Buiga, R., Pop, V., Irimie, A., Fodde, R., Bedrosian, I., Martens, J. W., Foekens, J. A., Berindan-Neagoe, I., & Calin, G. A.
Venue
Oncotarget
Published
2013-09-18
Volume
4
Issue
10
Pages
1748-1762
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2143144903
Cited by
176
References
4
FWCI
5.69
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.